Bisacodyl: Stimulant Laxative for Constipation
Bisacodyl is a stimulant laxative that has been in clinical use since the 1950s. It belongs to the diphenylmethane class of laxatives and works as a prodrug that is activated specifically in the colon. Due to its well-established efficacy and predictable onset of action, bisacodyl remains one of the most widely used laxatives worldwide and is available without prescription in standard doses in most countries.
A key characteristic of bisacodyl is the marked difference in onset time depending on the formulation. Enteric-coated tablets typically produce a bowel movement within 6 to 12 hours because the drug must first pass through the stomach and small intestine before reaching the colon. Suppositories, in contrast, act locally and produce an effect within 20 to 45 minutes. This makes suppositories preferable in situations requiring rapid bowel evacuation, such as pre-procedure preparation or acute constipation requiring quick relief.
Mechanism of Action
Bisacodyl is a prodrug that is hydrolyzed by endogenous esterases and colonic bacterial enzymes to its active form, bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM). This metabolite acts directly on the mucosa of the large intestine through two complementary mechanisms. First, it stimulates the enteric nervous system and smooth muscle of the colon, increasing peristaltic contractions and accelerating intestinal transit. Second, it reduces water and electrolyte reabsorption from the colon while simultaneously promoting secretion of water and electrolytes into the intestinal lumen, increasing stool water content and softening consistency. Because activation occurs predominantly in the colon, systemic absorption is minimal and the effect is largely localized. The enteric coating on tablets prevents gastric dissolution and premature absorption in the small intestine.
Indications
Bisacodyl is indicated for short-term treatment of occasional constipation. It is widely used for bowel preparation before diagnostic procedures (colonoscopy, radiological examination, surgery) and is included in many bowel prep kits for this purpose. In clinical settings, bisacodyl is used to restore bowel function after abdominal surgery and in patients with drug-induced constipation (for example, opioid-induced constipation in palliative care). Suppositories are used in patients who cannot swallow tablets and for evacuation before proctological examinations.
Dosage and Administration
Adults and children over 12 years: 5 to 10 mg orally once daily, preferably in the evening to achieve a morning bowel movement. Children aged 4 to 12 years: 5 mg once daily. Tablets must be swallowed whole with water; they must not be crushed or chewed. Tablets must not be taken within one hour of consuming milk or antacids, as alkaline pH dissolves the enteric coating prematurely, causing gastric irritation and loss of the targeted colonic release. Rectal suppositories (10 mg) are inserted once daily. Duration of use should not exceed seven days without medical advice. For bowel preparation, specific preparation protocols with higher doses apply under medical supervision.
Side Effects
Abdominal cramps, bloating, and nausea are the most common side effects and reflect the stimulation of intestinal smooth muscle. These symptoms are generally mild and transient. Diarrhea can occur with doses above the recommended range. Rectal burning or irritation may occur with suppository use. With prolonged or excessive use, electrolyte disturbances, particularly hypokalaemia (low potassium), can develop and may cause muscle weakness and cardiac arrhythmias. Excessive laxative use can lead to laxative dependence and bowel habituation, where the colon becomes increasingly reliant on stimulation. Allergic reactions including skin rash and anaphylaxis are rare but documented.
Interactions
Bisacodyl itself has minimal systemic pharmacokinetic interactions. However, the accelerated intestinal transit caused by bisacodyl can reduce the absorption of oral medications taken concurrently. For drugs with narrow therapeutic windows, timing of bisacodyl administration relative to other medications should be considered. Diuretics and corticosteroids combined with bisacodyl may increase the risk of electrolyte disturbances, particularly hypokalaemia. Milk and antacids must not be taken within one hour of bisacodyl tablets due to disruption of the enteric coating. Bisacodyl is not expected to interact significantly with anticoagulants, antiplatelet agents, or most cardiovascular drugs at recommended doses.
Special Notes
Bisacodyl is intended for short-term use only. Continuous use beyond one week without medical advice is not recommended and may indicate an underlying condition requiring diagnosis. Chronic stimulant laxative use can impair the natural motility of the colon over time. Bisacodyl should not be used in patients with ileus (bowel obstruction), acute abdominal conditions, severe dehydration, or inflammatory bowel disease during acute flares. Use in pregnancy should be limited to cases of necessity after medical consultation; the drug is not expected to cause teratogenic effects, but increased uterine motility is a theoretical concern. Bisacodyl does not replace dietary measures, adequate fluid intake, and physical activity as first-line approaches to constipation management.
Related Active Ingredients
Frequently Asked Questions
Why must bisacodyl tablets not be taken with milk?
Bisacodyl tablets have an enteric coating that dissolves only in the alkaline environment of the small intestine and colon, not in the acidic stomach. Milk, which has a near-neutral pH and contains calcium, raises gastric pH and can dissolve this coating prematurely. This leads to gastric irritation, premature drug release in the upper intestine, and loss of the targeted colonic effect. A gap of at least one hour between milk consumption and bisacodyl intake is required.
How quickly does a bisacodyl suppository work?
Bisacodyl suppositories are absorbed directly through the rectal mucosa and activate the local reflex arc of the colon without needing to pass through the digestive tract. The onset of action is typically 20 to 45 minutes after insertion, making suppositories significantly faster than tablets for situations where prompt bowel evacuation is needed.
Can bisacodyl be used long-term?
Bisacodyl is not suitable for long-term use without medical supervision. Chronic stimulant laxative use carries the risk of electrolyte imbalances (particularly low potassium), laxative dependence, and potential impairment of intrinsic bowel motility. For chronic constipation requiring regular management, osmotic laxatives such as macrogol are generally preferred as they have a more favorable long-term safety profile.
Sources
- Lacy BE et al: ACG Clinical Guideline: Chronic Constipation. Am J Gastroenterol 2021
- EMA: Bisacodyl Summary of Product Characteristics 2022
- Muller-Lissner SA et al: Bisacodyl is effective for bowel preparation. Dis Colon Rectum 2020